What is the recommended medical abortion regimen, including medication types, doses, routes of administration, timing, follow‑up, and contraindications, for a woman with an intra‑uterine pregnancy of ≤9 weeks gestation in India?

Medical Abortion Regimen for Early Pregnancy (≤9 weeks) in India

For a woman with confirmed intrauterine pregnancy ≤9 weeks gestation in India, administer mifepristone 200 mg orally followed by misoprostol 800 mcg vaginally, buccally, or sublingually 24–48 hours later, which achieves a 97.7% success rate and can be safely performed in outpatient or home settings. 1, 2, 3

Standard Medication Regimen

Primary Protocol

• Mifepristone 200 mg taken orally on Day 1, which blocks progesterone receptors and causes decidual breakdown of the uterine lining 1, 4
• Misoprostol 800 mcg administered 24–48 hours later (Day 2 or 3) via vaginal, buccal, or sublingual route 2, 3, 4
• The 24-hour interval is superior to simultaneous administration, though both are effective (96.9% vs 95.1% success rates) 5

Route Selection for Misoprostol

• Vaginal route: Most studied, highly effective, can be self-administered at home 2, 3
• Buccal route: Place tablets between cheek and gum for 30 minutes, then swallow remnants; equally effective as vaginal route 2, 3
• Sublingual route: 600 mcg dose achieves 98.3% success rate with rapid absorption and prolonged serum levels 6
• Avoid oral route: Associated with higher failure rates compared to vaginal, buccal, or sublingual administration 4

Gestational Age Considerations

• Highest efficacy at 29–42 days gestation (98.8% success rate) 3
• Acceptable efficacy through 63 days/9 weeks (95.5–97.7% success rate) 3, 4
• Success rates decline slightly with advancing gestational age, but the regimen remains highly effective throughout the first trimester 3, 4

Pre-Treatment Requirements

Mandatory Assessments

• Confirm intrauterine pregnancy via transvaginal ultrasound to exclude ectopic pregnancy 2
• Establish accurate gestational age using ultrasound or reliable last menstrual period 2
• Screen for contraindications including hemodynamic instability, known coagulopathy, or adrenal insufficiency 1

Rh Status Management

• All Rh-negative women should receive anti-D immunoglobulin prophylaxis 1, 7
• Dose: 50 mcg within 72 hours of mifepristone administration (or 300 mcg if 50 mcg unavailable) 1, 7

Absolute Contraindications

• Previous cesarean delivery or uterine scar: Misoprostol carries a 13% uterine rupture risk in this population—surgical abortion is mandatory 1, 7
• Confirmed ectopic pregnancy: Medical abortion is ineffective and dangerous 2
• Hemodynamic instability or active hemorrhage: Requires immediate surgical intervention 8
• Severe anemia (hemoglobin <7 g/dL): Stabilize before medical abortion or proceed with surgical evacuation 8

Expected Clinical Course

Normal Response

• Cramping and bleeding begin 1–4 hours after misoprostol administration 2
• Bleeding duration: Average 9–16 days, with heaviest flow in first 24–48 hours 2
• Expulsion timing: Most pregnancies expel within 4–6 hours of misoprostol 3

Symptom Management

• Pain control: NSAIDs (ibuprofen 400–600 mg every 6 hours) are first-line 2
• Nausea/vomiting: Antiemetics (ondansetron 4–8 mg) as needed 2
• Low-grade fever: Expected side effect of misoprostol; temperatures >38.5°C warrant evaluation for infection 2

Follow-Up Protocol

Timing and Methods

• Clinical assessment at 7–14 days post-treatment 2, 3
• Confirm complete abortion using one of three methods:
  • Serial quantitative β-hCG (should decline by ≥50% in 48 hours, reach <5 mIU/mL by 4 weeks) 2
  • Urine pregnancy test (negative by 4 weeks) 2
  • Transvaginal ultrasound (empty uterine cavity, endometrial thickness <14 mm) 8, 2

Treatment Failure Indicators

• Ongoing pregnancy: Persistent cardiac activity on ultrasound or rising β-hCG (occurs in 1.1% of cases) 4
• Incomplete abortion: Retained tissue with endometrial thickness ≥14 mm and vascularity, or plateauing β-hCG 8
• Management: Repeat misoprostol 800 mcg dose or proceed to surgical evacuation 2, 3

Serious Complications (Rare)

Infection Recognition

• Warning signs: Maternal tachycardia, purulent cervical discharge, uterine tenderness, fever >38.5°C 8, 7
• Action: Initiate broad-spectrum antibiotics immediately and perform urgent surgical evacuation 8, 7
• Incidence: Infection requiring hospitalization occurs in 0.01% of cases 3

Hemorrhage Management

• Definition: Soaking >2 pads per hour for 2 consecutive hours 2
• Action: Immediate evaluation; transfusion if hemoglobin <7 g/dL 8
• Incidence: Transfusion required in 0.03% of cases 3

Post-Abortion Contraception

• Ovulation resumes within 2–4 weeks after abortion 8, 7
• Initiate contraception immediately: Combined hormonal methods or implants can start on day of confirmed complete abortion 8
• No backup needed if started within 7 days of abortion completion 8

Critical Pitfalls to Avoid

• Do not use misoprostol in women with prior cesarean delivery—this is an absolute contraindication due to catastrophic uterine rupture risk 1, 7
• Do not delay treatment for infection signs; maternal sepsis can develop within 18 hours of initial symptoms 8
• Do not perform surgical evacuation solely for endometrial thickness <14 mm in stable patients—this represents overtreatment 8
• Do not withhold Rh immunoglobulin from Rh-negative women; fetomaternal hemorrhage occurs in 32% of spontaneous abortions 8, 7

Setting and Supervision

• Outpatient or home-based care is safe and appropriate for pregnancies ≤9 weeks 1, 2, 3
• Mifepristone administration can occur in clinic with immediate discharge 3
• Misoprostol self-administration at home 24–48 hours later is standard practice 2, 3
• Emergency contact information must be provided for 24/7 access to care 2